BIAL enters the US and acquires “promising” Parkinson’s disease programmes

News

Author: Simge Eva DoganPublished: 8 October 2020

Prep: Cook: Serves:

BIAL Parkinson's research and development department

Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease.

BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition.

António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide.

“The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs in the world and in one of the most promising areas of medicine.”

Lead image: research and development department at BIAL

Last Month

Next Month

Go Back

Share this story

Comments

Global update

“You’re superhuman up there”: Parkinson’s in space

Ex-astronaut Rich Clifford on why he decided to reveal his diagnosis

Scientific art: stunning Parkinson’s photos reveal beauty of the brain

Winning photo showcases the beautiful complexity of brain cells

New technology helps prevent PwPs from falling

Innovative remote management gait guidance system is to launch soon

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Researchers at the University of Pennsylvania, US, have found that people with early Parkinson’s disease are at higher risk of developing cognitive impairments if they are overweight, have disruptive sleep behaviours or experience symptoms of depression. Evaluating data from 405 people, the researchers used statistical analysis to identify relationships between certain characteristics and changes in patient cognition over time. Their findings suggest that factors such as high body mass index (BMI) or excessive sleepiness are associated with a faster rate of cognitive decline in Parkinson’s disease. The researchers wrote: “Despite its common and devastating occurrence, treatment of [cognitive impairments] in [Parkinson’s disease] is limited and no medications slow its onset or progression. However, identification of treatable or modifiable comorbidities that affect the rate of progression of [cognitive impairments] in [Parkinson’s disease] could provide opportunities for early intervention and improved prognosis.”

Gene screening technique could offer insights on Parkinson’s disease

Researchers from the Massachusetts Institute of Technology (MIT), US, will investigate genes that could protect cells in the brain against Parkinson’s disease. An award from US non-profit G Harold and Leila Y Mathers Foundation will allow scientists to use a mouse model screening technique to find out more about the condition. Individually deleting each of the 22,000 genes present in mice neurons will help identify which genes are linked to neuron survival – and offer insights that could lead to new treatments for the condition. Dr Myriam Heiman, an Associate Professor at MIT, said: “There is currently no molecular explanation for the brain cell loss seen in Parkinson’s disease or a cure for this devastating disease. I’m extremely grateful for this generous support and recognition of our work from the Mathers Foundation, and hope that our study will elucidate new therapeutic targets for the treatment and even prevention of Parkinson’s…

Can equine-assisted therapy benefit people with Parkinson’s disease?

Researchers from Texas Woman’s University, US, are investigating how equine-assisted therapy – which involves working with horses to promote wellbeing – can benefit people with Parkinson’s disease. As part of the five-month study, funded by the non-profit Human Animal Bond Research Institute, 30 men with Parkinson’s disease will be randomly assigned to participate in equine-assisted therapy or simulated horseback riding. The participants’ motor performance, balance, gait and symptoms related to Parkinson’s disease will be assessed before, during and after the therapy. Rhett Rigby, principal investigator of the study, said: “There is currently no known study that utilises equine-assisted therapy as an intervention treatment for those with Parkinson’s disease. Our research could have a significant impact on an understudied population and help contribute to the existing literature on human-animal interaction.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

News

Author: Simge Eva DoganPublished: 8 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

“You’re superhuman up there”: Parkinson’s in space

Europe

Scientific art: stunning Parkinson’s photos reveal beauty of the brain

Advances

New technology helps prevent PwPs from falling

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Gene screening technique could offer insights on Parkinson’s disease

Can equine-assisted therapy benefit people with Parkinson’s disease?

{title}

Subscribe

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

News

Author: Simge Eva DoganPublished: 8 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

“You’re superhuman up there”: Parkinson’s in space

Europe

Scientific art: stunning Parkinson’s photos reveal beauty of the brain

Advances

New technology helps prevent PwPs from falling

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Gene screening technique could offer insights on Parkinson’s disease

Can equine-assisted therapy benefit people with Parkinson’s disease?

{title}

Subscribe

Sign in